| Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen JF Daisne, T Duprez, B Weynand, M Lonneux, M Hamoir, H Reychler, ... Radiology 233 (1), 93-100, 2004 | 803 | 2004 |
| Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms JF Daisne, M Sibomana, A Bol, T Doumont, M Lonneux, V Grégoire Radiotherapy and oncology 69 (3), 247-250, 2003 | 491 | 2003 |
| Inter-observer variability in the delineation of pharyngo-laryngeal tumor, parotid glands and cervical spinal cord: comparison between CT-scan and MRI X Geets, JF Daisne, S Arcangeli, E Coche, M De Poel, T Duprez, ... Radiotherapy and oncology 77 (1), 25-31, 2005 | 228 | 2005 |
| Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer JP Machiels, C Sempoux, P Scalliet, JC Coche, Y Humblet, E Van Cutsem, ... Annals of Oncology 18 (4), 738-744, 2007 | 192 | 2007 |
| Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised … J Giralt, J Trigo, S Nuyts, M Ozsahin, K Skladowski, G Hatoum, JF Daisne, ... The Lancet Oncology 16 (2), 221-232, 2015 | 184 | 2015 |
| Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency JF Daisne, M Sibomana, A Bol, G Cosnard, M Lonneux, V Grégoire Radiotherapy and Oncology 69 (3), 237-245, 2003 | 184 | 2003 |
| Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation JF Daisne, A Blumhofer Radiation oncology 8, 1-11, 2013 | 175 | 2013 |
| Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: Disease-free … HJ Schmoll, K Haustermans, TJ Price, B Nordlinger, R Hofheinz, ... Journal of clinical oncology 32 (15_suppl), 3501-3501, 2014 | 163* | 2014 |
| Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre-and per … X Geets, JF Daisne, M Tomsej, T Duprez, M Lonneux, V Grégoire Radiotherapy and oncology 78 (3), 291-297, 2006 | 151 | 2006 |
| Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT X Geets, JF Daisne, V Gregoire, M Hamoir, M Lonneux Radiotherapy and Oncology 71 (3), 267-273, 2004 | 99 | 2004 |
| Pre-and postoperative capecitabine without or with oxaliplatin in locally advanced rectal cancer: PETACC 6 trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD HJ Schmoll, A Stein, E Van Cutsem, T Price, RD Hofheinz, B Nordlinger, ... Journal of Clinical Oncology 39 (1), 17-29, 2021 | 85 | 2021 |
| Primary tumor delineation based on 18FDG PET for locally advanced head and neck cancer treated by chemo-radiotherapy M Leclerc, E Lartigau, T Lacornerie, JF Daisne, A Kramar, V Grégoire Radiotherapy and Oncology 116 (1), 87-93, 2015 | 83 | 2015 |
| Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of … HJ Schmoll, K Haustermans, TJ Price, B Nordlinger, R Hofheinz, ... Journal of Clinical Oncology 31 (15_suppl), 3531-3531, 2013 | 80 | 2013 |
| Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical … S Nuyts, M Lambrecht, F Duprez, JF Daisne, D Van Gestel, ... Radiotherapy and Oncology 109 (2), 323-329, 2013 | 78 | 2013 |
| Reduction of the dose of radiotherapy to the elective neck in head and neck squamous cell carcinoma; a randomized clinical trial. Effect on late toxicity and tumor control D Nevens, F Duprez, JF Daisne, R Dok, A Belmans, M Voordeckers, ... Radiotherapy and Oncology 122 (2), 171-177, 2017 | 77 | 2017 |
| How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement Y Lievens, N Defourny, J Corral, C Gasparotto, C Grau, JM Borras, ... The Lancet Oncology 21 (1), e42-e54, 2020 | 67 | 2020 |
| Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. V Grégoire, JF Daisne, X Geets, P Levendag Rays 28 (3), 217-224, 2003 | 55 | 2003 |
| Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine+/-oxaliplatin in locally advanced rectal cancer: Final results of PETACC-6. HJ Schmoll, K Haustermans, TJ Price, B Nordlinger, R Hofheinz, ... Journal of Clinical Oncology 36 (15_suppl), 3500-3500, 2018 | 52 | 2018 |
| Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long-term tumor outcome S Deschuymer, D Nevens, F Duprez, JF Daisne, R Dok, A Laenen, ... Radiotherapy and Oncology 143, 24-29, 2020 | 39 | 2020 |
| Radiotherapy induced dermatitis is a strong predictor for late fibrosis in head and neck cancer. The development of a predictive model for late fibrosis D Nevens, F Duprez, JF Daisne, A Laenen, W De Neve, S Nuyts Radiotherapy and Oncology 122 (2), 212-216, 2017 | 35 | 2017 |
